Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Roviello

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Medical Oncology (Northwood, London, England)|May 21, 2017
Advances in systemic therapy for metastatic breast cancer: future perspectivesS P Corona, N Sobhani, A Ianza, et al.
Medical Oncology (Northwood, London, England)|June 16, 2017
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectivesS P Corona, N Sobhani, A Ianza, et al.
Cancer Chemotherapy and Pharmacology|June 13, 2019
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancerG Roviello, F U Conter, E Mini, et al.
International Reviews of Immunology|June 18, 2020
Evaluation of targetable biomarkers for chimeric antigen receptor T-cell (CAR-T) in the treatment of pancreatic cancer: a systematic review and meta-analysis of preclinical studiesMaryam Sahlolbei, Mohsen Dehghani, Behghat Kheiri Yeghane Azar, et al.
ESMO Open|September 24, 2022
Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysisB A Maiorano, U De Giorgi, G Roviello, et al.
Medical Oncology (Northwood, London, England)|February 1, 2015
Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experienceR Petrioli, G Roviello, A I Fiaschi, et al.
Journal of Cancer Research and Clinical Oncology|May 18, 2021
EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experienceAnna Ianza, A Di Chicco, C Biagi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 4, 2015
Surgical management of advanced gastric cancer: An evolving issueL Marano, K Polom, A Patriti, et al.
Molecular Biology Reports|March 7, 2019
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesotheliomaN Sobhani, G Roviello, T Pivetta, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 28, 2023
Gender and cystectomy for bladder cancer: A high-volume tertiary urologic care center experienceA Mariotti, P Spatafora, F Sessa, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Medical Oncology (Northwood, London, England)|May 21, 2017
Advances in systemic therapy for metastatic breast cancer: future perspectivesS P Corona, N Sobhani, A Ianza, et al.
Medical Oncology (Northwood, London, England)|June 16, 2017
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectivesS P Corona, N Sobhani, A Ianza, et al.
Cancer Chemotherapy and Pharmacology|June 13, 2019
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancerG Roviello, F U Conter, E Mini, et al.
International Reviews of Immunology|June 18, 2020
Evaluation of targetable biomarkers for chimeric antigen receptor T-cell (CAR-T) in the treatment of pancreatic cancer: a systematic review and meta-analysis of preclinical studiesMaryam Sahlolbei, Mohsen Dehghani, Behghat Kheiri Yeghane Azar, et al.
ESMO Open|September 24, 2022
Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysisB A Maiorano, U De Giorgi, G Roviello, et al.
Medical Oncology (Northwood, London, England)|February 1, 2015
Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experienceR Petrioli, G Roviello, A I Fiaschi, et al.
Journal of Cancer Research and Clinical Oncology|May 18, 2021
EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experienceAnna Ianza, A Di Chicco, C Biagi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 4, 2015
Surgical management of advanced gastric cancer: An evolving issueL Marano, K Polom, A Patriti, et al.
Molecular Biology Reports|March 7, 2019
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesotheliomaN Sobhani, G Roviello, T Pivetta, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 28, 2023
Gender and cystectomy for bladder cancer: A high-volume tertiary urologic care center experienceA Mariotti, P Spatafora, F Sessa, et al.
Pageof 3